AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 278: F830-F838, 2000;
0363-6127/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isono, M.
Right arrow Articles by Ziyadeh, F. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isono, M.
Right arrow Articles by Ziyadeh, F. N.
Vol. 278, Issue 5, F830-F838, May 2000

Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney

Motohide Isono*, András Mogyorósi*, Dong Cheol Han, Brenda B. Hoffman, and Fuad N. Ziyadeh

Renal-Electrolyte and Hypertension Division, Department of Medicine, and Penn Center for the Molecular Studies of Kidney Diseases, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6144

Transforming growth factor-beta (TGF-beta ) is important in the pathogenesis of diabetic nephropathy, but little is known about the regulation of the ligand-binding TGF-beta type II signaling receptor (Tbeta IIR). There were significant increases in Tbeta IIR protein and mRNA levels in kidney cortex after 1-6 wk of streptozotocin-induced diabetes. Mouse mesangial cells cultured in high glucose demonstrated significantly increased Tbeta IIR protein and mRNA levels compared with normal glucose. This effect was independent of stimulation of TGF-beta bioactivity by high glucose. Consistent with transcriptional activation by high glucose, the half-life (~4 h) of Tbeta IIR mRNA was not affected by glucose concentration. Moreover, mouse mesangial cells transiently transfected with reporter constructs containing the first 47- or 274-bp promoter fragments of Tbeta IIR demonstrated significantly increased reporter activity in high glucose. Cells grown in high glucose demonstrated increased responsiveness to a relatively small dose of exogenous TGF-beta 1 (0.5 ng/ml): [3H]proline incorporation and alpha 1(IV) collagen mRNA were significantly greater in cells cultured in high than in normal glucose. Hence, the expression of Tbeta IIR is increased in the diabetic kidney and in mesangial cells cultured in high glucose, primarily because of stimulation of gene transcription. Tbeta IIR upregulation by high ambient glucose may contribute to the increased sensitivity of mesangial cells to the profibrogenic action of TGF-beta 1.

diabetic nephropathy; glomerulosclerosis; type IV collagen; glomerulus; transforming growth factor-beta

* M. Isono and A. Mogyorósi contributed equally to this work.




This article has been cited by other articles:


Home page
 DiabetesHome page
L. Mahimainathan, F. Das, B. Venkatesan, and G. G. Choudhury
Mesangial Cell Hypertrophy by High Glucose Is Mediated by Downregulation of the Tumor Suppressor PTEN.
Diabetes, July 1, 2006; 55(7): 2115 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Hayashida and H. W. Schnaper
High Ambient Glucose Enhances Sensitivity to TGF-{beta}1 via Extracellular Signal--Regulated Kinase and Protein Kinase C{delta} Activities in Human Mesangial Cells
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2032 - 2041.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Dai and Y. Liu
Hepatocyte Growth Factor Antagonizes the Profibrotic Action of TGF-{beta}1 in Mesangial Cells by Stabilizing Smad Transcriptional Corepressor TGIF
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1402 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. N. Ziyadeh
Mediators of Diabetic Renal Disease: The Case for TGF-{beta} as the Major Mediator
J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S55 - 57.
[Abstract] [Full Text]

Home page
 HypertensionHome page
C. Lindschau, P. Quass, J. Menne, F. Guler, A. Fiebeler, M. Leitges, F. C. Luft, and H. Haller
Glucose-Induced TGF-{beta}1 and TGF-{beta} Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-{alpha}
Hypertension, September 1, 2003; 42(3): 335 - 341.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Susztak, K. Sharma, M. Schiffer, P. McCue, E. Ciccone, and E. P. Bottinger
Genomic Strategies for Diabetic Nephropathy
J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S271 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. Gore-Hyer, D. Shegogue, M. Markiewicz, S. Lo, D. Hazen-Martin, E. L. Greene, G. Grotendorst, and M. Trojanowska
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F707 - F716.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Eickelberg, M. Centrella, M. Reiss, M. Kashgarian, and R. G. Wells
Betaglycan Inhibits TGF-beta Signaling by Preventing Type I-Type II Receptor Complex Formation. GLYCOSAMINOGLYCAN MODIFICATIONS ALTER BETAGLYCAN FUNCTION
J. Biol. Chem., January 4, 2002; 277(1): 823 - 829.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online